NANOVIRICIDES, INC. — Director's Dealing 2015

Sep 25, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NANOVIRICIDES, INC. (NNVC)
CIK: 0001379006
Period of Report: 2015-09-22

Reporting Person: Diwan Anil (Director, President, 10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2015-09-22	Common Stock, par value $0.001 per share	M	208771	$0.35	Acquired	2082310	Direct
2015-09-22	Common Stock, par value $0.001 per share	F	76944	$1.30	Disposed	2005366	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2015-09-22	Common Stock Options	$0.35	M	285715	Disposed	2015-09-26	Common Stock (285715)	Direct

Footnotes

F1: Does not include 571,429 shares of Series A Convertible Preferred Stock (the "Series A Preferred Stock") which votes at the rate of nine shares of Common Stock per each share of Series A and is convertible into three and one half shares of Common Stock upon a change in control of the Company or upon achieving certain trading prices of the Common Stock. Also does not include 16,531,429 shares owned by TheraCour Pharma, Inc. (calculating the Series A, over which Dr. Diwan holds voting and dispositive power.

F2: Reflects 76,944 shares withheld by the Issuer at the market price of $1.30 per share, less an exercise price of $0.35 per share, to fund the cashless exercise of 208,771 options.